Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial analysis".

AuthorsZiad Hijazi, Stefan H Hohnloser, Jonas Oldgren, Ulrika Andersson, Stuart J Connolly, John W Eikelboom, Michael D Ezekowitz, Paul A Reilly, Agneta Siegbahn, Salim Yusuf, Lars Wallentin
JournalCirculation (Circulation) Vol. 130 Issue 22 Pg. e195 (Nov 25 2014) ISSN: 1524-4539 [Electronic] United States
PMID25421051 (Publication Type: Comment, Letter)
Chemical References
  • Benzimidazoles
  • beta-Alanine
  • Warfarin
  • Atrial Fibrillation (drug therapy, physiopathology)
  • Benzimidazoles (adverse effects, therapeutic use)
  • Female
  • Humans
  • Kidney (physiology)
  • Male
  • Warfarin (adverse effects, therapeutic use)
  • beta-Alanine (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: